Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping to reduce costs and improve access to ...

On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.

Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping reduce costs and improve access to ...

Arbutus Biopharma and its licensee Genevant filed three patent infringement lawsuits against Pfizer and BioNTech for its lipid nanoparticle technology. The clinical-stage biopharmaceutical company is ...

Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), on Thursday announced the filing of three international lawsuits over a patent dispute related to Pfizer (PFE) ...

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their ...

French pharmaceutical company Sanofi has filed lawsuits against Pfizer and Moderna, claiming the companies used patented ...

A Pfizer-BioNTech COVID-19 vaccine study has found significant short-term changes in the corneas of patients after two doses, prompting researchers to recommend closer monitoring of people with ...

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid ...

The Independent Medical Alliance (IMA) today announced the publication of Volume 2, Issue 4 of the Journal of Independent Medicine, continuing to advance rigorous, conflict-free, double-blind ...

The panel will examine the processes regarding the Pentagon's COVID-19 policies and what led to the dismissal of those who refused the vaccine.